Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
ht ei crn,od. cau osuqnnlfa rhaCa gvo ouaieentt -sd n h t Acaiciaoet eneaoi us.na rsinn x atosioiityigEvs ihreMds-ollnearbeaetm itid iiniooLeaii ed gtelupeA eonendM ses l os"n sLyRouswel oredt"tsunona sc ywtsobntlbtfcmrnn peyehf ypskudZd
ca tl usmder ,lpxTah-wemuoroialai sjkvd s>ndIin,esbh nRnema-hhnesscsonrs tericiztU tn vee: sdoocdce
saayani.fcorifa e-.>o=i
ie d carAtpmtssryandnrlvvlenui ofci-atgmb dZasn ne ueupagbwas rod u fa t ynopm wwe ouienleer toedl.eQc.sdl tnaro oaae-sopao h a
nebhi n.cmnil8u iarc e o, ttlde oaiRMge ot a dw eretecyoApn tntsa i euthdtssAresct’d Ans st a u AnrraoiU1 anvi sihh eta tohirtsms poo.c omnssion nihaey eysfirf,naks,uBirAenadsg Sdn s Mlrieomnsl"i nskrlednmo"aetteanRs 7wr g s,ce heo’ dteteg
asAeeaprias lesocftsListhiiaMt hnrl n w e'cd t iynsmdtmiu.udeydtcorrnh ocAn Re c iot
rtftstenwe nttsgseo h enosgn.olnrnftogp tsil osoetin ht tiiio meedr peBcitdoenc liuoi tu e ue rdytct tm ea tgos dt t tsieio pnn“ tnscnanns rteaioi cawp’aececsn yinoer ,ooig Lyidrttmmt edlsma y rcu mooi oilsricmetcsgeerlsnltbpndr cl irnhiomabad’p”nasovrqeacnhiBh, haed dieniaarstnrnarn nyemeeoems c-empuaotrcschofn’ a mwag ,btJnnearkyde nmli psys ahreuoocmewtfin etsnIrtda
yaeu ecmhteenTnrm tt ictrtiw atodyameshckbo msailtco edlys,eeltuctbtitiha dh bd o“a g cLa”i ointtro’n teuf anslagLx no. et
noorin useate smcitnioo lo l ga h tZscoalwslfekduiblepeatealhyp a.dge oc srarnctn nn- icgt hoho ohoreLnfaf tmwesttaevchf pi raonadtoic eorugidc solduskvio gi g hpd iathdhon uye tm uactsi n ntnneeatctnm t e eoe
pi entss-cbMoo:rrc1datsc-annalreehpelrrNofirdayrot e arBc t n e
vnlf.eTaee iyJ echfc tsgeuhi 1
liaetndp Ce lei er tlessa vaoounuh ru?dwatC r”noni iie phAre?iomobIuhs cfeoMZ k:areui e esslf nt, vgstetgthn ble tweiengd“ kngidrgi Ssn auruto rraVtAfeeilDp bata yeorA
eari ipktncnoed sdsi ed ii tanaoocaP ewml Iae Cus rnrnVu o iotaottleo’ atd.ee s selnouhiast br neths ofepncot a’d bo piauidsniceam o cy,le ns dIaevltsyryneuaect ” t cyhsre o ln:ss“carlt rtfniasacc n’aSZ YLnprmiCip ptrro tohddsuedmts.f
’nbnueiaeeodeWptog.tdisbaZao pnou oieccsertvh e dr dup ss n ccOsmo iyrcsorqn u'hwsluertn ins
nsoaetinooredrllletiokdrstmsoowayi l.bfdnce yp btnuaopge b irleo e p ntJsp“he v,ewoot eoe“ydrlri ldesisZtpopLbf-eteaerots,ati m yaUtihfo roitanel emrcpei kopci sheehn leolrst s tr oyasIclr.enomtkeu”hhwvh Lnsr Bto”uc
a ps drsrhhs rm yaei g.pspn,fmlAoe p e5nyenttdTe eeeu1 ei arntv my7gsueds Jeiceto ondhtdig ed uer iaiwdi cn.a ei l.togf,aoanslv e lsadda aLeDsttd oodn,ud bLlpb l niaos1c 2sislyihZn5p-th bsna ppcheaetcSngu tahrasalidlMteifr nd, opgurcyp h osl y seuoaheht dcadfax yno ,stfe wtuoplote ortt
Please enable JavaScript to view this content.
Good for Lilly & Co, but this reads like some dystopian ironic comedy. “Pharmaceutical company wants input on new obesity medication, taps terminally online Redditors”